Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Eden vs Enhance MD

Two GLP-1 providers, one scoreboard. We put Eden and Enhance MD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 2 · Grade A−

Eden

Visit Eden Full brief →

FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.

vs
No. 11 · Grade B

Enhance MD

Visit Enhance MD Full brief →

The verdict

Eden takes this head-to-head.

Eden scores 91 to 85 on our six-factor Brief Score — A polished, high-disclosure program with strong nationwide coverage — you pay more, but you know exactly what you're paying for.

That doesn't make Enhance MD a bad call — it's best for readers who want to see the whole price ladder before they commit and value dose-flat billing plus routine lab work — and who don't need brand-name or oral options. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
89
86
Supply Reliability
92
84
Transparency
93
88
Access Breadth
90
80
Clinical Oversight
92
87
Track Record
89
82
EdenBrief Score 91 · 85Enhance MD

Price, coverage & the tracker

EdenEnhance MD
Brief Score91/100 (A−)85/100 (B)
Semaglutide$198/mo all-in — $99/mo for the medication plus the $99/mo Eden membership it cannot be bought without ($138 the first month, when membership is $39); compounded$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay
Tirzepatide$298/mo all-in — $199/mo for the medication plus the required $99/mo membership ($238 the first month); compounded$329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay
CoverageAll 50 statesNot publicly listed
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerFallingprice fallingStableprice stable

Eden: Re-read 28 August 2026 and restated: Eden advertises compounded semaglutide at $99/mo and tirzepatide at $199/mo, but its own footnote says medication cannot be bought without an Eden membership that costs $39 the first month and $99/mo after — so the real monthly cost is $198 and $298. That is below the $239 and $349 we carried before, so the direction is down even after adding the fee back in. Brand-name Ozempic, Zepbound and Mounjaro ($1,399/mo) and Wegovy ($1,695/mo) are sold here too.

Enhance MD: The ladder is fully published, but its rungs are prepay blocks: $212 and $280 are the 12-MONTH rates, while month-to-month is $249 and $329 — and every plan bills every 4 weeks, so a "monthly" plan is 13 charges a year. The $112 is $212 less a dated SUMMER50 coupon, not an entry rate.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.